G.-C. Wang et al. / Phytochemistry 96 (2013) 201–207
205
125.0), one carboxyl group (dC 167.2), two methyl groups (dC 17.9,
19.2) and one glucose moiety (dC 95.9, 74.0, 78.8, 71.0, 78.1, 62.3).
These 1H and 13C NMR spectroscopic data were similar to those of
an isolated known compound 1b-hydroxy-eudesma-4,11(13)-
dien-12-oic acid (14) (Ohmoto et al., 1987), except for the presence
of an extra sugar moiety, suggesting that 10 was another eudesmane
glycoside. In addition, the correlationbetween H-10 (dH 5.57) and C-1
(dC 79.0) in HMBC spectrum indicated that the sugar moiety was
Sephadex LH-20 (Pharmacia, NJ, USA), respectively. All solvents
used in CC were of analytical grade (Tianjin Damao Chemical Plant,
Tianjin, P.R. China). Preparative high-performance liquid chroma-
tography (HPLC) was performed on a Varian chromatograph
equipped with a Prostar 215 pump, a Prostar 325 UV–VIS detector,
using a C18 reversed-phase column (Cosmosil, 20 ꢀ 250 mm, 5
lm).
4.2. Plant material
connected to C-1. Acid hydrolysis of 10 yielded D-glucose which
was identified by the method mentioned above (Tanaka et al.,
2007). The characteristic coupling constant of the anomeric proton
Whole plants of L. alata (D. Don) Sch. Bip. ex Oliv were collected
from Guangxi Medicinal Plant Garden in September, 2008, and
identified by Research Assistant You-Bao Huang of Guangxi Medic-
inal Plant Garden. A voucher specimen (No. 08091309) is deposited
in the Institute of Traditional Chinese Medicine and Natural Prod-
ucts, College of Pharmacy, Jinan University (Guangzhou, China).
(J = 7.9 Hz) indicated that it was a b-
D-glucoside. Therefore, 10 was
elucidated as 1b-O-(b- -glucopyranosyloxyl)-eudesma-4,11(13)-
D
dien-12-oic acid, and named alatoside H.
Recently, quite a few studies have focused on anticancer activi-
ties of sesquiterpenes, including eudesmane-type sesquiterpenes
(Cui et al., 2011; Dai et al., 2009; Minakawa et al., 2012; Tanaka
et al., 2012; Wang et al., 2007; Xu et al., 2010). The cytotoxic activi-
ties of some eudesmane-type sesquiterpene derivatives from L.
pterodonta were also investigated (Xiao et al., 2003). Therefore, the
present study tested the cytotoxic activities of all the isolated eudes-
mane-type sesquiterpenes with MTT assay on six human cancer cell
lines including MFC-7 (human breast carcinoma cell), A375 (human
melanoma cell), A549 (human lung carcinoma epithelial cell), Hep-2
(human larynx epidermoid carcinoma cell), CNE (human nasopha-
ryngeal carcinoma epithelia cell), and Hela (human cervical carci-
noma cell). However, all of the compounds were inactive on the
4.3. Extraction and isolation
The air-dried whole plants of L. alata (4.5 kg) were powdered
and percolated with EtOH–H2O (95:5, v/v) at room temperature
for three times. The extract was then concentrated in vacuo to yield
a residue (540 g), which was dissolved in EtOH–H2O (1:9, v/v) and
subjected to Diaion HP-20 macrosporous resin CC successively
eluted with EtOH–H2O mixtures (1:9, 3:7, 6:4, 9:1, v/v). The frac-
tion (70 g) eluted by EtOH–H2O (6:4, v/v) was concentrated and
then subjected to a silica gel CC (CHCl3–MeOH, 100:0 ? 50:50)
to afford 10 fractions. Fraction 2 (8.7 g) was separated by ODS silica
gel CC (MeOH–H2O, 15:85 ? 80:20) to give five subfractions
(2a–e). Subfraction 2b was purified by Sephadex LH-20 CC (CHCl3–
MeOH, 1:1) and preparative HPLC (MeOH–H2O, 70:30, v/v) to yield
compounds 1 (39 mg), 2 (28 mg), 3 (21 mg) and 19 (40 mg),
respectively. Compound 7 (25 mg) was recrystallized from subfrac-
tion 3c. Further purification of subfraction 3c by Sephadex LH-20
(CHCl3–MeOH, 1:1) and preparative HPLC (MeOH–H2O, 60:40,
v/v) afforded compounds 12 (28 mg), 13 (12 mg) and 14 (15 mg).
By similar procedures, compounds 11 (35 mg), 19 (29 mg) and 20
(18 mg) were obtained from subfraction 3d. Fraction 5 (5.9 g)
was subjected to silica gel CC using a petroleum ether (PE)–EtOAc
gradient as eluent, and then purified by preparative HPLC (MeOH–
H2O, 60:40, v/v) to give compounds 4 (21 mg), 5 (12 mg) and 15
(18 mg). Fraction 6 (6.1 g) was separated by a silica gel CC eluting
with gradient CHCl3–MeOH, and further purified by Sephadex LH-
20 (CHCl3–MeOH, 1:1) and preparative HPLC (MeOH–H2O, 50:50,
v/v) to afford compounds 6 (18 mg), 16 (16 mg) and 18 (24 mg),
respectively. Compounds 9 (14 mg), 21 (20 mg) and 22 (25 mg)
were isolated from fraction 7 (4.1 g) by ODS CC with a MeOH–
H2O gradient and preparative HPLC (MeOH–H2O (40:60, v/v)).
Fraction 9 (2.8 g) was purified by Sephadex LH-20 (CHCl3–MeOH,
1:1) and preparative HPLC (MeOH–H2O, 35:65, v/v) to give
compounds 8 (23 mg), 10 (16 mg) and 17 (34 mg).
tested cell lines in the concentration of 100 lg/mL.
3. Concluding remarks
Eudesmane sesquiterpenes are the primary chemical constitu-
ents of Laggera species, which is consistent with the results of this
study on L. alata. To the best of our knowledge, three cuauhtemone
derivatives had been previously reported from L. alata (Zdero and
Bohlmann, 1989), and this paper added 22 cuauhtemone derivatives
into the current list of the compounds isolated from the plant. More-
over, there were no such compounds reported to be isolated from
L. pterodonta, another Laggera plant found in China. This was helpful
in chemotaxonomical classifications. It is noteworthy that the ste-
reochemistry of the cuauhtemone derivatives determined in this pa-
per by single crystal X-ray diffraction analysis and modified
Mosher’s method is consistent with that proposed by Nakanishi
et al. (1974), rather than that described by Torres-Valencia et al.
(2003). Quite a few reports concerned the anticancer activities of
eudesmane-type sesquiterpenes (Cui et al., 2011; Dai et al., 2009;
Minakawa et al., 2012; Tanaka et al., 2012; Xu et al., 2010); however,
in the present study, the eudesmane sesquiterpenes isolated from L.
alata possessed no cytotoxic effects on human cancer cell lines.
4. Experimental
4.3.1. (3R,4S,5R,6R,20R,30S)-3-O-(20,30-Diacetoxy-20-methylbutyryl)-
4.1. General experimental procedures
cuauhtemone (1)
Colorless blocks; mp 118–120 °C, ½a D25
ꢁ
+21.6 (c 0.2, MeOH); UV
(MeOH) kmax: 254 nm; IR (KBr) mmax: 3473, 2942, 2867, 1739, 1449,
Melting points were obtained on an X-5 micro-melting point
apparatus. Optical rotations were recorded on a JASCO P-1020
polarimeter, whereas IR spectra were measured on a JASCO FT/IR-
480 plus infrared spectrometer with KBr pellets. UV spectra were
acquired on a JASCO V-550 UV/VIS spectrometer. HRESIMS data
were determined on an Agilent 6210 ESI/TOF mass spectrometer.
1D NMR (1H, 13C, and DEPT) and 2D (1H–1H COSY, HSQC, HMBC,
and ROESY) NMR spectra were recorded on a Bruker Avance 400
or 500 NMR spectrometer with TMS as internal standard, and chem-
ical shifts were expressed in d values (ppm). Column chromatogra-
phy (CC) employed silica gel (200–300 mesh; Qingdao Marine
Chemical Inc., Qingdao, P.R. China), ODS (YMC, Kyoto, Japan) and
1372, 1197, 1143, 952, 607, 526 cmꢂ1; for 1H NMR (CDCl3,
500 MHz) and 13C NMR (CDCl3, 125 MHz) spectroscopic data, see
Tables 1 and 2; HRESIMS m/z: 475.2310 [M+Na]+ (calcd for
C24H26O8Na, 475.2302).
4.3.2. 4-O-Acetyl-3-O-(30-acetoxy-20-hydroxy-20-methylbutyryl)-
cuauhtemone (2)
Brown oil, ½a 2D5
ꢁ
+21.0 (c 0.2, MeOH); UV (MeOH) kmax: 254 nm;
IR (KBr) mmax: 3475, 2939, 2867, 1736, 1448, 1375, 1195, 1145, 942,
615 cmꢂ1; for 1H NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3,